Evaluating the Prognostic Value of ACQ-5 Scores in Predicting Asthma Exacerbations
Using Blood Markers to Predict Asthma Attacks and Guide Treatment Success
This meta-analysis evaluates how baseline ACQ-5 scores correlate with future asthma attacks and the efficacy of mepolizumab in diverse patie…
Doctors are finding that specific blood markers are better than standard surveys at predicting severe asthma attacks and choosing the right …
FF/UMEC/VI Triples Odds of Asthma Clinical Remission at 52 Weeks
Trial shows triple therapy improves outcomes for uncontrolled asthma patients
In this 52-week, open-label randomized trial of 1236 adults with uncontrolled, infrequently exacerbating asthma, fluticasone furoate/umeclid…
A new triple-medication inhaler significantly increases the odds of achieving clinical remission for adults with uncontrolled, stable asthma…
Spatial oligonucleotide immuno-reprogramming model provides a conceptual research framework for multiple myeloma study
New Research Framework Explores Oligonucleotides for Multiple Myeloma Treatment
This narrative review describes the Spatial oligonucleotide immuno-reprogramming model (SOIRM) as a conceptual and testable research framewo…
A new conceptual framework called SOIRM explores how spatially targeted oligonucleotides might one day help treat multiple myeloma.
SPP1 perturbation improves anti-PD-1 and adoptive cell therapy responses in colorectal cancer models
New research explores ways to improve colorectal cancer treatments
This mini review explores the role of SPP1 and lipid-related pathways in colorectal cancer peritoneal metastases. The authors suggest that S…
Scientists are investigating how targeting specific proteins and lipids can help immune therapies work better for colorectal cancer patients…
Bispecific antibody therapy achieves 65.54% objective response rate in relapsed or refractory multiple myeloma
New bispecific antibodies show promise for relapsed multiple myeloma
This meta-analysis of 4,045 patients evaluates GPRC5D and BCMA targeted bispecific antibodies for relapsed or refractory multiple myeloma. T…
New bispecific antibody treatments show a 65.54% response rate for patients with relapsed or refractory multiple myeloma.
Climate awareness and motivation factors influence meat consumption choices in children and adolescents
Climate awareness can help children and teens eat less meat
This mini review synthesizes evidence regarding the impact of climate awareness on dietary choices in children and adolescents. The review i…
New research shows that teaching kids about the climate can influence their food choices and their plans for eating less meat in the future.
Immunocytokines offer improved safety profiles compared to systemic cytokine therapy in cancer treatment
Newer cancer treatments may offer safer options for patients
This narrative review examines immunocytokines including IL-2, IL-12, and TNF-alpha based constructs for cancer treatment. The authors concl…
Newer versions of immune-boosting drugs may offer a safer way to treat cancer by reducing the severe side effects of older therapies.
FDA Approves Claritin (loratadine) for Hay Fever and Upper Respiratory Allergy Symptoms
FDA Approves Claritin for Hay Fever and Allergy Symptom Relief
The FDA has approved Claritin for temporary relief of symptoms due to hay fever or other upper respiratory allergies, including runny nose, …
The FDA has approved Claritin for temporary relief of hay fever and other upper respiratory allergy symptoms. It treats runny nose, itchy wa…
Mtb antigen-induced IP-10 shows pooled sensitivity 0.81 and specificity 0.88 for latent TB
New Blood Test Marker Shows Promise for Detecting Hidden Tuberculosis Infections
This meta-analysis of 24 studies (2,014 participants) evaluated Mycobacterium tuberculosis antigen-induced interferon-gamma-inducible protei…
A new protein marker in the blood helps doctors identify people with hidden tuberculosis infections more accurately.
Tumor-intrinsic mechanisms like attenuated IFNGR-JAK-STAT1 responsiveness and altered antigen presentation impact bladder cancer immunity
New insights into why some bladder cancer treatments fail
This mini review explores the role of interferon-gamma (IFN-gamma) associated immunity checkpoints in bladder cancer models. The authors syn…
Researchers identified specific ways bladder cancer cells can block the immune system from responding to standard treatments like BCG.
Umbilical cord blood-derived extracellular vesicles show promise for postpartum alopecia in preclinical models
Cord blood components may help hair regrowth after childbirth
This systematic review examines the potential of umbilical cord blood-derived extracellular vesicles (UCB-EVs) for treating postpartum alope…
New research explores how cord blood-derived particles could help women regrow hair lost after giving birth.
Immune checkpoint inhibitor and chemotherapy combination improves pathological response in gastric adenocarcinoma
Immune therapy combined with chemotherapy improves gastric cancer outcomes
This systematic review and meta-analysis of 74 trials evaluates neoadjuvant and perioperative strategies for locally advanced gastric and ga…
Adding immune checkpoint inhibitors to chemotherapy can significantly improve response rates and survival for patients with advanced stomach…